Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease Carlos González-Muñoza; Cristina Gely; Jordi Gordillo; Margalida Calafat; Federico Bertoletti; Fiorella Cañete; Míriam Mañosa; Alberto López-Faba; Paola Torres; Eugeni Domènech; Esther Garcia-Planella;

Changes in the intensified regimen of infliximab in patients with inflammatory bowel disease in sustained remission: Reflections on a series of cases Laura Gutiérrez-Rios; Eva Vayreda; Margalida Calafat; Fiorella Cañete; Eugeni Domènech; Míriam Mañosa;

Mesalazine dose modification based on faecal calprotectin levels in patients with ulcerative colitis in clinical remission Gisela Piñero; Míriam Mañosa; Margalida Calafat; Eva Vayreda; Fiorella Cañete; Maria Puig; Eugeni Domènech;